Therapeutic translation of iPSCs for treating neurological disease.
about
Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapyThe Application of Human iPSCs in Neurological Diseases: From Bench to BedsideStem cell imaging: from bench to bedsideSchizophrenia as a disorder of molecular pathwayshPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice.Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term cultureUtilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neuronsStem cell therapy for Alzheimer's disease and related disorders: current status and future perspectivesToward pluripotency by reprogramming: mechanisms and applicationWnt-YAP interactions in the neural fate of human pluripotent stem cells and the implications for neural organoid formationAdvances in microfluidic platforms for analyzing and regulating human pluripotent stem cells.Preconditioning stem cells for in vivo delivery.Adult Hippocampal Neurogenesis, Fear Generalization, and Stress.Suppression of histone deacetylation promotes the differentiation of human pluripotent stem cells towards neural progenitor cells.The microenvironment of embryoid bodies modulated the commitment to neural lineage postcryopreservation.FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions5-HT2 receptors mediate functional modulation of GABAa receptors and inhibitory synaptic transmissions in human iPS-derived neurons.Vitamin C alleviates aging defects in a stem cell model for Werner syndromePredicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiologyStem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.iPS cells: a game changer for future medicine.Combining insoluble and soluble factors to steer stem cell fate.Induced pluripotent stem cells and their use in cardiac and neural regenerative medicineHuman pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autismEngineering of Adult Neurogenesis and Gliogenesis.Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells.MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.Simple derivation of transgene-free iPS cells by a dual recombinase approach.A Microfluidic Platform for the Characterisation of CNS Active Compounds.Cryopreservation of embryonic stem cell-derived multicellular neural aggregates labeled with micron-sized particles of iron oxide for magnetic resonance imaging.Generation of Neural Progenitor Spheres from Human Pluripotent Stem Cells in a Suspension Bioreactor.Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell derived neurons.High-throughput mapping of brain-wide activity in awake and drug-responsive vertebrates.Ultrastructural analysis of murine hippocampal neural progenitor cells in culture.[Induced pluripotent stem cells. A new resource in modern medicine].Long-term fate of grafted hippocampal neural progenitor cells following ischemic injury.Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.
P2860
Q26749360-E7DB6439-953C-4B3C-8AEF-94BA59CDECB8Q26765876-C8DDE056-4326-4E07-99FE-DE0C1BF1D61DQ26861615-68126EA4-B2B9-4726-986D-CA30B5D9B3A8Q26865937-83543D69-F84A-40DD-B1D6-62AFE570A418Q27303692-13B194CA-4FC1-4183-BC55-3D9DB7359FF7Q27314513-783DA614-7BF2-47A1-84C4-858311F3017BQ28081565-A7396DF7-E17C-43A1-876A-EDADC07DE100Q28085612-6F420F4E-8032-4505-89B7-0414C3F0789EQ28833688-2F90FBFF-FCB4-4D74-8370-5752960786B8Q28973608-0FA55433-2C13-4D01-8BB5-62562ADBBDA0Q30373146-53150640-D645-4DF2-8798-0BD8D47B11CBQ33998015-87EA51F0-D164-4895-9789-963221687FC6Q34480465-9280D7B5-F129-4937-9291-CD61545E533FQ34623528-54895B18-8887-4243-B349-624BC301EA8EQ35245728-4CFE5E6B-37C4-4F9D-ABF1-285E909755A5Q36073654-C9EA7FCE-D213-4EAB-9F99-56C611FA9972Q36536141-C72DBED8-4BE5-40EF-9F0C-ED81DA4928CBQ37059940-6D9D04DA-BAA7-49C5-90A0-9977CABD8174Q37351739-06DD0CE5-A537-42CB-A337-36520CCC7ACAQ37643268-2249A332-4DB9-4A6B-9BCA-01232B16D06BQ37652595-4FD10AEC-CD4D-44FB-B0B3-11AF069C5451Q38185513-D5EE39B5-4D44-46EC-9B03-9E32D511FB4EQ38213259-B4BD91D0-BE13-485F-8FA7-C0EAF19A999FQ38358569-6ADD7CFF-0FBF-477C-BC37-2DB6E9D3AB90Q38428477-83483FC4-7E5E-45F8-8352-76EE0492E336Q38662603-D6E05A43-091F-43D2-A145-FC08082C04EEQ38811601-8D8C5397-44C1-41E2-8502-47DF2FCC5394Q38820849-13ABAD8E-BA4A-44EE-9705-E7604898229FQ40994304-78A3F3A6-C443-4D60-8555-2ACA549F4818Q42228486-85845E66-B1AB-4173-A5F1-855BAA60CCE3Q44462403-A7E1440D-4232-4D6B-BF74-32AB90E4BEE3Q46738511-604E07F8-D790-4EA9-BB25-95B87392BDA2Q47588620-BF5FE74C-AE40-43EE-8947-845625F31CB9Q48022573-48D7BEF2-9D25-4219-98F1-F2C50A8CE3FAQ48183777-7C1EC6F5-602E-4286-95E3-738C7B337C65Q48453438-B7251C92-0AC7-45CC-BE37-A0F2362BE4E1Q48455476-0A21752C-65D7-45FF-ADEF-98E5470A4FCAQ48887430-0606F039-AAA4-44A2-BD66-13DF1062C6D2Q50457361-FCCFD249-50A5-436B-A546-113D8593F3A3Q52568314-026E2B03-4F20-4175-A4E0-EA4199D6F6C2
P2860
Therapeutic translation of iPSCs for treating neurological disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Therapeutic translation of iPSCs for treating neurological disease.
@en
Therapeutic translation of iPSCs for treating neurological disease.
@nl
type
label
Therapeutic translation of iPSCs for treating neurological disease.
@en
Therapeutic translation of iPSCs for treating neurological disease.
@nl
prefLabel
Therapeutic translation of iPSCs for treating neurological disease.
@en
Therapeutic translation of iPSCs for treating neurological disease.
@nl
P2093
P1433
P1476
Therapeutic translation of iPSCs for treating neurological disease.
@en
P2093
Diana X Yu
Fred H Gage
Maria C Marchetto
P304
P356
10.1016/J.STEM.2013.05.018
P407
P577
2013-06-01T00:00:00Z